Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (551)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
134
2025
2934
10.010
Why?
Gene Expression Regulation, Neoplastic
53
2025
824
3.340
Why?
Drug Resistance, Neoplasm
25
2020
315
3.180
Why?
Gene Expression Profiling
43
2023
1029
2.810
Why?
Cell Proliferation
25
2022
987
2.220
Why?
Plasma Cells
23
2025
221
2.200
Why?
Antineoplastic Agents
29
2020
1176
2.130
Why?
Cell Line, Tumor
45
2025
1390
1.930
Why?
Monoclonal Gammopathy of Undetermined Significance
8
2024
112
1.920
Why?
Neoplastic Stem Cells
7
2020
100
1.670
Why?
Pyrazines
19
2023
187
1.580
Why?
Paraproteinemias
9
2024
72
1.450
Why?
Mice
46
2025
5673
1.430
Why?
Lymphoma, B-Cell
5
2021
61
1.420
Why?
Disease Progression
18
2024
821
1.390
Why?
Boronic Acids
17
2014
182
1.370
Why?
Bone Resorption
6
2024
297
1.370
Why?
Apoptosis
17
2022
1093
1.360
Why?
Humans
154
2025
50201
1.360
Why?
Tumor Microenvironment
6
2024
222
1.250
Why?
Animals
56
2025
13141
1.220
Why?
Neoplasm Proteins
7
2021
321
1.190
Why?
Prognosis
36
2024
1963
1.140
Why?
Osteolysis
4
2022
75
1.120
Why?
B-Lymphocytes
8
2021
175
1.080
Why?
Cell Cycle Proteins
4
2023
166
1.040
Why?
T-Lymphocytes
8
2024
329
1.000
Why?
Hematopoietic Stem Cell Transplantation
6
2024
556
1.000
Why?
Ubiquitination
3
2021
40
0.950
Why?
Proteasome Inhibitors
7
2020
104
0.920
Why?
Signal Transduction
21
2023
1612
0.880
Why?
MicroRNAs
7
2022
349
0.830
Why?
Proteasome Endopeptidase Complex
4
2018
116
0.830
Why?
Antigens, CD
8
2024
216
0.770
Why?
Neoplasms
3
2024
1233
0.750
Why?
Carrier Proteins
3
2017
302
0.680
Why?
CDC2-CDC28 Kinases
3
2015
11
0.670
Why?
Cation Transport Proteins
2
2019
27
0.650
Why?
Up-Regulation
6
2020
446
0.630
Why?
Ubiquitins
2
2016
39
0.630
Why?
Cyclin-Dependent Kinases
2
2010
26
0.630
Why?
Glycolysis
3
2022
68
0.620
Why?
Mice, Inbred NOD
5
2020
94
0.620
Why?
Oligonucleotide Array Sequence Analysis
19
2014
409
0.620
Why?
Waldenstrom Macroglobulinemia
1
2018
40
0.610
Why?
Proto-Oncogene Proteins c-akt
5
2023
155
0.600
Why?
Chromosome Aberrations
6
2023
295
0.590
Why?
Cell Differentiation
9
2023
648
0.590
Why?
Iron
2
2017
122
0.590
Why?
Pyrimidines
3
2015
192
0.580
Why?
STAT3 Transcription Factor
4
2016
80
0.570
Why?
Killer Cells, Natural
5
2024
107
0.570
Why?
Cell Survival
10
2020
590
0.570
Why?
Pyruvate Kinase
1
2017
7
0.560
Why?
Ascorbic Acid
1
2017
22
0.560
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1000
0.550
Why?
RNA Splicing
1
2017
37
0.550
Why?
Protein-Tyrosine Kinases
2
2015
94
0.520
Why?
Down-Regulation
9
2019
342
0.510
Why?
Cyclopentanes
1
2015
10
0.500
Why?
Transplantation, Autologous
5
2024
463
0.500
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
67
0.500
Why?
Thalidomide
10
2023
374
0.490
Why?
Aldehyde Dehydrogenase
1
2014
25
0.480
Why?
Osteoclasts
7
2023
424
0.480
Why?
Dexamethasone
7
2024
434
0.470
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
17
0.460
Why?
Female
44
2024
26829
0.450
Why?
Models, Biological
5
2018
722
0.440
Why?
Hematologic Neoplasms
1
2015
99
0.440
Why?
Receptors, Retinoic Acid
2
2013
22
0.440
Why?
Cystatin M
2
2024
19
0.440
Why?
Male
34
2024
25572
0.430
Why?
RNA, Messenger
13
2021
1097
0.430
Why?
B-Cell Maturation Antigen
2
2024
89
0.420
Why?
Flow Cytometry
8
2018
475
0.420
Why?
Antigens, Neoplasm
6
2014
146
0.410
Why?
Glucuronidase
4
2018
48
0.410
Why?
Predictive Value of Tests
5
2016
921
0.390
Why?
Antibodies, Bispecific
2
2023
71
0.380
Why?
Mice, Transgenic
6
2021
542
0.370
Why?
Syndecan-1
6
2017
72
0.370
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.370
Why?
Arsenicals
1
2010
14
0.370
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.370
Why?
Oxides
1
2010
18
0.360
Why?
Reverse Transcriptase Polymerase Chain Reaction
12
2015
579
0.350
Why?
Janus Kinase 1
1
2010
16
0.350
Why?
Proto-Oncogene Proteins c-jun
2
2009
75
0.350
Why?
MAP Kinase Kinase 1
1
2010
23
0.350
Why?
Immunotherapy, Adoptive
2
2024
159
0.350
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
81
0.340
Why?
DNA-Binding Proteins
4
2021
424
0.340
Why?
Early Growth Response Protein 1
1
2009
33
0.330
Why?
Transcription Factors
6
2022
563
0.330
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
104
0.330
Why?
Tretinoin
1
2009
53
0.320
Why?
Oligopeptides
3
2015
95
0.320
Why?
Xenograft Model Antitumor Assays
7
2019
212
0.320
Why?
Osteogenesis
5
2023
353
0.310
Why?
NF-kappa B
3
2018
315
0.310
Why?
Genes, Neoplasm
1
2008
30
0.300
Why?
Tumor Cells, Cultured
6
2020
462
0.300
Why?
Antibodies
3
2024
151
0.300
Why?
Aged
24
2024
9505
0.300
Why?
Microarray Analysis
3
2018
73
0.300
Why?
Chromosomes, Human, Pair 1
4
2023
92
0.290
Why?
Immunologic Factors
5
2015
112
0.280
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.280
Why?
Interleukin-6
3
2019
266
0.280
Why?
Neoplasms, Plasma Cell
2
2023
37
0.280
Why?
Tumor Suppressor Protein p53
2
2008
214
0.280
Why?
Small Molecule Libraries
2
2019
67
0.280
Why?
Pyrazoles
2
2020
111
0.280
Why?
Mice, SCID
9
2018
173
0.260
Why?
Protein Kinase Inhibitors
3
2024
205
0.260
Why?
CD8-Positive T-Lymphocytes
3
2024
123
0.260
Why?
Risk Factors
11
2018
3644
0.250
Why?
Genomics
2
2023
284
0.240
Why?
Survival Rate
8
2020
906
0.240
Why?
Middle Aged
23
2024
12356
0.240
Why?
Enzyme Inhibitors
4
2019
378
0.240
Why?
Bone Diseases
4
2016
97
0.240
Why?
Polycomb Repressive Complex 2
2
2021
46
0.240
Why?
Bone Marrow
7
2024
356
0.240
Why?
Single-Cell Analysis
1
2025
63
0.230
Why?
Hydroxybenzoates
1
2024
18
0.230
Why?
Receptors, LDL
1
2024
67
0.230
Why?
Propionates
1
2024
22
0.230
Why?
Ferritins
1
2024
30
0.230
Why?
TNF Receptor-Associated Factor 3
2
2022
13
0.230
Why?
Myeloid Progenitor Cells
1
2023
17
0.220
Why?
X-Ray Microtomography
1
2024
78
0.220
Why?
Histocompatibility Antigens Class I
2
2015
44
0.220
Why?
Cholesterol
1
2024
148
0.220
Why?
Melphalan
3
2023
173
0.220
Why?
Antigens, CD19
3
2018
26
0.220
Why?
Neoplasms, Second Primary
1
2024
74
0.220
Why?
Bone Marrow Cells
4
2015
190
0.220
Why?
Cell Transformation, Neoplastic
1
2024
181
0.220
Why?
Membrane Glycoproteins
6
2009
244
0.220
Why?
Genes, myc
3
2019
40
0.220
Why?
Intercellular Signaling Peptides and Proteins
4
2007
100
0.220
Why?
Lymphoma
1
2024
65
0.220
Why?
Bone Diseases, Metabolic
1
2024
73
0.210
Why?
Phenols
1
2024
80
0.210
Why?
Cluster Analysis
5
2009
233
0.210
Why?
Homeostasis
1
2024
203
0.210
Why?
Bone and Bones
2
2021
477
0.210
Why?
Gene Knockdown Techniques
3
2018
106
0.210
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
4
0.210
Why?
Recurrence
7
2018
660
0.210
Why?
Protein Binding
2
2018
655
0.210
Why?
Neutropenia
1
2023
114
0.210
Why?
Periodontitis
1
2022
10
0.200
Why?
Randomized Controlled Trials as Topic
6
2016
553
0.200
Why?
Reactive Oxygen Species
4
2017
406
0.200
Why?
Case-Control Studies
8
2020
1145
0.200
Why?
Antibodies, Monoclonal
3
2013
459
0.200
Why?
In Situ Hybridization, Fluorescence
5
2023
256
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
154
0.200
Why?
Protein Stability
2
2020
43
0.200
Why?
Kaplan-Meier Estimate
5
2016
463
0.190
Why?
Osteoporosis
1
2023
156
0.190
Why?
Arthritis, Rheumatoid
1
2022
105
0.190
Why?
Adult
20
2024
13486
0.190
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.190
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.190
Why?
RANK Ligand
1
2022
179
0.190
Why?
Ubiquitin-Protein Ligases
2
2020
93
0.190
Why?
Venous Thromboembolism
3
2011
67
0.190
Why?
Oxidative Stress
4
2016
763
0.190
Why?
Phenylpropionates
1
2021
13
0.180
Why?
Hippurates
1
2021
10
0.180
Why?
Gene Expression
4
2017
612
0.180
Why?
Cell Cycle
4
2010
226
0.180
Why?
Proteolysis
3
2017
96
0.180
Why?
Bone Neoplasms
2
2015
178
0.180
Why?
Membrane Proteins
3
2017
347
0.180
Why?
Colonic Neoplasms
1
2022
158
0.180
Why?
Adaptor Proteins, Signal Transducing
1
2021
197
0.180
Why?
Protease Inhibitors
3
2011
58
0.180
Why?
Cell Movement
2
2015
245
0.180
Why?
Treatment Outcome
12
2020
5203
0.180
Why?
Colorectal Neoplasms
2
2022
255
0.180
Why?
Receptors, G-Protein-Coupled
1
2021
54
0.180
Why?
Antigens, CD20
2
2014
6
0.180
Why?
Retrospective Studies
7
2024
6190
0.180
Why?
Neoplasm Metastasis
4
2015
235
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
54
0.180
Why?
Time Factors
8
2021
2909
0.180
Why?
Disease-Free Survival
7
2016
450
0.170
Why?
Evolution, Molecular
1
2021
97
0.170
Why?
Chromosomal Instability
3
2021
16
0.170
Why?
Cytotoxicity, Immunologic
4
2015
56
0.170
Why?
Clinical Trials as Topic
1
2022
468
0.170
Why?
Tumor Suppressor Proteins
2
2019
127
0.170
Why?
Neoplasm Recurrence, Local
1
2024
630
0.170
Why?
DNA, Single-Stranded
1
2020
89
0.160
Why?
NF-E2-Related Factor 2
1
2019
42
0.160
Why?
Oncogene Proteins
1
2019
17
0.160
Why?
Mitosis
3
2015
88
0.160
Why?
Carcinoma, Neuroendocrine
1
2019
23
0.160
Why?
Transplantation, Heterologous
2
2017
75
0.160
Why?
Healthcare Disparities
1
2022
279
0.160
Why?
rab GTP-Binding Proteins
1
2019
37
0.160
Why?
Receptors, Interleukin-6
1
2018
22
0.160
Why?
Proto-Oncogene Proteins c-myc
2
2017
50
0.160
Why?
Drug Tolerance
1
2018
59
0.160
Why?
Neovascularization, Pathologic
3
2009
153
0.160
Why?
Pyridines
1
2019
132
0.150
Why?
Blotting, Western
3
2015
587
0.150
Why?
Lung Neoplasms
1
2024
601
0.150
Why?
Drug Therapy, Combination
2
2017
382
0.150
Why?
beta Catenin
2
2015
101
0.140
Why?
M Phase Cell Cycle Checkpoints
1
2017
4
0.140
Why?
Mice, Knockout
4
2023
840
0.140
Why?
Hydroxamic Acids
2
2014
38
0.140
Why?
Aerobiosis
1
2017
14
0.140
Why?
Microfilament Proteins
1
2017
42
0.140
Why?
Thyroid Hormones
1
2017
18
0.140
Why?
Onium Compounds
1
2016
13
0.140
Why?
Calcium-Binding Proteins
1
2017
54
0.140
Why?
Organophosphorus Compounds
1
2016
15
0.140
Why?
Deoxyglucose
1
2016
36
0.140
Why?
Histone Deacetylase Inhibitors
2
2014
57
0.140
Why?
Survival Analysis
6
2020
670
0.140
Why?
Inhibitor of Apoptosis Proteins
3
2015
20
0.130
Why?
Syndecans
3
2006
34
0.130
Why?
Gene Deletion
2
2008
267
0.130
Why?
Pancreatic Neoplasms
1
2019
209
0.130
Why?
Aged, 80 and over
7
2021
3158
0.130
Why?
RNA Interference
2
2015
178
0.130
Why?
Cell Death
1
2016
174
0.130
Why?
Ribosomal Proteins
1
2016
25
0.130
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
42
0.130
Why?
Proteoglycans
3
2006
81
0.130
Why?
Proto-Oncogene Proteins
2
2009
150
0.130
Why?
Macrophages
2
2022
362
0.130
Why?
Oncolytic Virotherapy
1
2015
18
0.130
Why?
Gene Dosage
2
2013
78
0.130
Why?
Cell Adhesion Molecules
1
2015
87
0.130
Why?
Polysaccharides
1
2015
51
0.120
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
43
0.120
Why?
Receptors, Transferrin
1
2015
16
0.120
Why?
Side-Population Cells
1
2015
3
0.120
Why?
Lentivirus
1
2015
17
0.120
Why?
Retinal Dehydrogenase
1
2014
10
0.120
Why?
Serine Endopeptidases
2
2006
51
0.120
Why?
Receptors, Cell Surface
1
2015
120
0.120
Why?
Adenine
1
2015
31
0.120
Why?
Caspase 3
2
2022
93
0.120
Why?
Serum
1
2014
32
0.120
Why?
Cell Lineage
1
2014
83
0.120
Why?
Proto-Oncogene Proteins c-kit
1
2014
36
0.120
Why?
Superoxide Dismutase
1
2014
113
0.120
Why?
Translocation, Genetic
4
2021
263
0.120
Why?
Piperidines
1
2015
96
0.110
Why?
Tumor Burden
3
2020
131
0.110
Why?
Cyclins
3
2015
38
0.110
Why?
HLA Antigens
1
2014
53
0.110
Why?
Alkaline Phosphatase
2
2011
94
0.110
Why?
Glycoproteins
1
2014
115
0.110
Why?
Repressor Proteins
4
2015
149
0.110
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.110
Why?
Leukemia, Plasma Cell
1
2013
33
0.110
Why?
Lactate Dehydrogenases
1
2013
1
0.110
Why?
Phenotype
4
2009
732
0.110
Why?
Genome, Human
2
2021
110
0.110
Why?
Follow-Up Studies
5
2024
2188
0.110
Why?
Intercellular Adhesion Molecule-1
1
2013
61
0.110
Why?
Dose-Response Relationship, Drug
4
2020
1356
0.110
Why?
Scavenger Receptors, Class A
1
2013
39
0.100
Why?
Leukemia
1
2013
64
0.100
Why?
Disease Models, Animal
4
2020
1419
0.100
Why?
bcl-X Protein
1
2013
53
0.100
Why?
Heat-Shock Proteins
1
2013
105
0.100
Why?
RNA, Neoplasm
3
2007
45
0.100
Why?
RNA, Small Interfering
2
2010
210
0.100
Why?
Forkhead Transcription Factors
2
2023
110
0.100
Why?
Clinical Trials, Phase III as Topic
2
2012
46
0.100
Why?
Cysteine Proteinase Inhibitors
1
2011
22
0.100
Why?
Drug Screening Assays, Antitumor
3
2020
131
0.100
Why?
Activated Protein C Resistance
1
2011
10
0.100
Why?
Factor V
1
2011
11
0.100
Why?
Protein Isoforms
2
2009
118
0.090
Why?
Acetylcysteine
1
2011
102
0.090
Why?
Glucocorticoids
1
2013
230
0.090
Why?
Interferon Regulatory Factor-1
1
2010
14
0.090
Why?
Cell Growth Processes
1
2010
22
0.090
Why?
HLA-A Antigens
2
2007
10
0.090
Why?
Gene Silencing
2
2007
114
0.090
Why?
Alleles
2
2021
253
0.090
Why?
Cells, Cultured
6
2015
1587
0.090
Why?
Epigenesis, Genetic
2
2023
371
0.080
Why?
Thrombosis
1
2012
249
0.080
Why?
K562 Cells
3
2016
41
0.080
Why?
Immunophenotyping
5
2010
111
0.080
Why?
Microtubule-Associated Proteins
1
2009
65
0.080
Why?
Recombinant Proteins
1
2010
480
0.080
Why?
Bone Remodeling
1
2010
149
0.080
Why?
Chromosome Mapping
2
2006
158
0.080
Why?
Thromboembolism
1
2009
54
0.080
Why?
Neoplasm Staging
3
2024
749
0.080
Why?
Mutation
3
2021
1288
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
ras Proteins
2
2020
64
0.080
Why?
Neoplasm Transplantation
2
2020
84
0.080
Why?
Angiogenesis Inhibitors
1
2009
182
0.080
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
8
0.070
Why?
Patient Selection
1
2009
254
0.070
Why?
Adoptive Transfer
1
2007
30
0.070
Why?
Genes, abl
1
2007
2
0.070
Why?
Protein Tyrosine Phosphatases
1
2007
24
0.070
Why?
Breast Neoplasms
2
2007
1187
0.070
Why?
Gene Expression Regulation
2
2022
964
0.070
Why?
HEK293 Cells
2
2019
217
0.070
Why?
Cancer Vaccines
1
2007
78
0.070
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
71
0.070
Why?
Drug Evaluation, Preclinical
2
2021
145
0.070
Why?
Caspases
1
2007
104
0.070
Why?
Cyclin D
1
2006
18
0.070
Why?
Chromosome Banding
1
2006
24
0.070
Why?
Proportional Hazards Models
2
2024
408
0.070
Why?
Models, Genetic
1
2006
174
0.070
Why?
Palatine Tonsil
2
2003
11
0.070
Why?
Peptides
1
2007
221
0.070
Why?
DNA Damage
1
2008
300
0.070
Why?
Maf Transcription Factors, Large
1
2005
1
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2007
178
0.060
Why?
Data Interpretation, Statistical
1
2006
159
0.060
Why?
Doxorubicin
2
2018
234
0.060
Why?
Protein Kinases
1
2005
70
0.060
Why?
Cyclin D1
1
2005
56
0.060
Why?
Antibody Formation
1
2005
51
0.060
Why?
Protein Biosynthesis
2
2003
251
0.060
Why?
Mice, Inbred C57BL
2
2021
1782
0.060
Why?
Papillomaviridae
1
2005
102
0.060
Why?
Cystadenocarcinoma, Serous
1
2004
71
0.060
Why?
Carcinoma, Papillary
1
2004
49
0.060
Why?
Base Sequence
3
2015
653
0.060
Why?
Transcription, Genetic
1
2005
369
0.060
Why?
Transfection
2
2020
354
0.060
Why?
Mice, Inbred BALB C
2
2019
296
0.060
Why?
Drug Synergism
2
2014
152
0.060
Why?
Jurkat Cells
2
2014
28
0.060
Why?
Zebrafish Proteins
1
2003
20
0.060
Why?
Genetic Predisposition to Disease
1
2007
508
0.060
Why?
Extracellular Matrix Proteins
1
2004
69
0.060
Why?
Adipogenesis
1
2024
49
0.060
Why?
Ovariectomy
1
2024
113
0.060
Why?
Steroids
1
2024
56
0.060
Why?
Sequence Analysis, RNA
1
2024
88
0.050
Why?
PPAR gamma
1
2024
72
0.050
Why?
Integrin beta Chains
1
2023
13
0.050
Why?
Integrins
1
2023
30
0.050
Why?
Oxidative Phosphorylation
1
2023
40
0.050
Why?
Chromosomes, Human, Pair 13
1
2003
38
0.050
Why?
Receptors, Fibroblast Growth Factor
1
2002
8
0.050
Why?
Cytogenetic Analysis
1
2023
80
0.050
Why?
Chromosomes, Human, Pair 4
1
2002
31
0.050
Why?
Chromosomes, Human, Pair 14
1
2002
75
0.050
Why?
Macrophage Activation
1
2022
25
0.050
Why?
Oncogene Proteins, Fusion
1
2002
59
0.050
Why?
Chromosome Deletion
1
2023
140
0.050
Why?
Computational Biology
2
2020
214
0.050
Why?
Porphyromonas gingivalis
1
2022
14
0.050
Why?
Geography
1
2022
61
0.050
Why?
Chromatin
1
2023
138
0.050
Why?
Uterine Cervical Neoplasms
1
2005
277
0.050
Why?
Diploidy
3
2007
26
0.050
Why?
Inflammasomes
1
2022
62
0.050
Why?
DNA, Neoplasm
1
2002
146
0.050
Why?
Models, Animal
2
2015
228
0.050
Why?
Mutation Rate
1
2021
36
0.050
Why?
DNA Primers
2
2015
207
0.050
Why?
Clone Cells
1
2021
78
0.050
Why?
Proteins
1
2003
348
0.050
Why?
Genes, Tumor Suppressor
1
2021
73
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
HCT116 Cells
1
2020
23
0.040
Why?
DNA Copy Number Variations
1
2021
109
0.040
Why?
Ovarian Neoplasms
1
2004
450
0.040
Why?
Double-Blind Method
2
2014
682
0.040
Why?
Cytokines
3
2009
607
0.040
Why?
Wnt Signaling Pathway
1
2021
91
0.040
Why?
3' Untranslated Regions
1
2020
52
0.040
Why?
Software
1
2002
273
0.040
Why?
Immunohistochemistry
3
2009
973
0.040
Why?
Gene Knockout Techniques
1
2019
40
0.040
Why?
Drug Discovery
1
2020
83
0.040
Why?
DNA
1
2023
543
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
Crystallography, X-Ray
1
2019
148
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
168
0.040
Why?
Protein Phosphatase 2
1
2019
4
0.040
Why?
G1 Phase
1
2019
13
0.040
Why?
Protein Conformation
1
2019
165
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
Multivariate Analysis
1
2021
581
0.040
Why?
Mice, Nude
1
2019
252
0.040
Why?
Immunotherapy
1
2021
235
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.040
Why?
Structure-Activity Relationship
1
2020
394
0.040
Why?
Wnt Proteins
2
2013
100
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
77
0.040
Why?
Phosphorylation
1
2020
525
0.040
Why?
DNA Methylation
1
2023
546
0.040
Why?
Drug Resistance
1
2018
64
0.040
Why?
Autophagy
1
2020
167
0.040
Why?
Cross-Sectional Studies
1
2022
1580
0.040
Why?
Cell Cycle Checkpoints
1
2017
30
0.040
Why?
Cell Hypoxia
1
2016
82
0.030
Why?
Biological Transport
1
2016
171
0.030
Why?
Chronic Disease
1
2019
568
0.030
Why?
Endoplasmic Reticulum Stress
1
2016
42
0.030
Why?
Models, Statistical
2
2008
225
0.030
Why?
Drug Interactions
1
2016
208
0.030
Why?
Mice, Inbred ICR
1
2016
22
0.030
Why?
Cell Line
2
2013
1010
0.030
Why?
Microscopy, Electron, Transmission
1
2015
75
0.030
Why?
Transcriptional Activation
1
2016
121
0.030
Why?
Pharmacogenetics
2
2006
50
0.030
Why?
Vidarabine
1
2015
9
0.030
Why?
Mitoxantrone
1
2015
9
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
47
0.030
Why?
Vincristine
1
2015
85
0.030
Why?
China
1
2015
86
0.030
Why?
Vaccination
2
2007
275
0.030
Why?
Prednisone
1
2015
101
0.030
Why?
Ligands
1
2015
203
0.030
Why?
Molecular Targeted Therapy
1
2016
121
0.030
Why?
Disulfiram
1
2014
10
0.030
Why?
Glutathione Peroxidase
1
2014
23
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
Risk Assessment
2
2009
1255
0.030
Why?
Microscopy, Fluorescence
1
2015
164
0.030
Why?
Cyclophosphamide
1
2015
164
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Glucose
1
2016
339
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
39
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
11
0.030
Why?
Chemotherapy, Adjuvant
1
2014
121
0.030
Why?
Lectins, C-Type
1
2013
30
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.030
Why?
Isoxazoles
1
2013
14
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
17
0.030
Why?
Glutathione
1
2014
297
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
32
0.030
Why?
Hedgehog Proteins
1
2013
33
0.030
Why?
Sulfones
1
2013
24
0.030
Why?
Itraconazole
1
2013
41
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, Glucocorticoid
1
2013
32
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Azacitidine
1
2013
34
0.030
Why?
Oxidants
1
2013
54
0.030
Why?
ADP-ribosyl Cyclase
2
2003
5
0.030
Why?
Epitopes
1
2013
58
0.030
Why?
Hydrocortisone
1
2013
107
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
96
0.030
Why?
MAP Kinase Signaling System
1
2013
118
0.030
Why?
Prospective Studies
2
2010
2396
0.030
Why?
Hydrogen Peroxide
1
2013
114
0.030
Why?
Histone Deacetylases
1
2013
50
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
127
0.030
Why?
Radiation, Ionizing
1
2013
97
0.030
Why?
Osteoblasts
2
2006
451
0.030
Why?
Transcriptome
1
2014
316
0.020
Why?
Clinical Trials, Phase II as Topic
1
2012
46
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Risk
1
2011
315
0.020
Why?
Bone Density Conservation Agents
1
2010
74
0.020
Why?
Diphosphonates
1
2010
90
0.020
Why?
Databases as Topic
1
2009
37
0.020
Why?
Parathyroid Hormone
1
2010
147
0.020
Why?
Lymphocytes
1
2010
154
0.020
Why?
Cytoskeleton
1
2008
41
0.020
Why?
Genotype
1
2009
542
0.020
Why?
Twins
1
2007
33
0.020
Why?
STAT Transcription Factors
1
2007
8
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
224
0.020
Why?
Cytological Techniques
1
2007
14
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
NF-kappa B p50 Subunit
1
2007
16
0.020
Why?
I-kappa B Kinase
1
2007
20
0.020
Why?
Karyotyping
1
2007
83
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
65
0.020
Why?
HLA-A2 Antigen
1
2007
11
0.020
Why?
Benzamides
1
2007
50
0.020
Why?
Antigen Presentation
1
2007
25
0.020
Why?
Remission Induction
1
2007
206
0.020
Why?
Polysaccharide-Lyases
1
2007
6
0.020
Why?
Leukocytes, Mononuclear
1
2007
113
0.020
Why?
Plasmids
1
2007
164
0.020
Why?
Tissue Culture Techniques
1
2007
37
0.020
Why?
Enzyme Activation
1
2007
270
0.020
Why?
Interferon-gamma
1
2007
176
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
234
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Anticoagulants
1
2009
253
0.020
Why?
Piperazines
1
2007
118
0.020
Why?
Neoplasms, Experimental
1
2007
111
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
49
0.020
Why?
Dendritic Cells
1
2007
133
0.020
Why?
Diagnosis, Differential
1
2010
1041
0.020
Why?
Incidence
1
2009
1000
0.020
Why?
Receptors, Estrogen
1
2007
130
0.020
Why?
Polymerase Chain Reaction
1
2007
456
0.020
Why?
Chromosomes, Human
1
2006
41
0.020
Why?
Gelatinases
1
2006
32
0.020
Why?
Endopeptidases
1
2006
66
0.020
Why?
Rabbits
1
2006
376
0.020
Why?
Coculture Techniques
1
2006
143
0.020
Why?
Combined Modality Therapy
1
2007
639
0.020
Why?
Cyclin D3
1
2005
5
0.020
Why?
Cyclin D2
1
2005
20
0.020
Why?
Trisomy
1
2005
31
0.020
Why?
Adipocytes
1
2006
121
0.020
Why?
Oligonucleotide Probes
1
2004
20
0.020
Why?
Stem Cells
1
2006
171
0.010
Why?
Epithelium
1
2004
65
0.010
Why?
Molecular Sequence Data
1
2006
795
0.010
Why?
Endothelium, Vascular
1
2006
252
0.010
Why?
Ovary
1
2004
114
0.010
Why?
Endothelial Cells
1
2006
257
0.010
Why?
Databases, Factual
1
2007
660
0.010
Why?
Bacterial Proteins
1
2007
372
0.010
Why?
RNA, Complementary
1
2003
2
0.010
Why?
Autocrine Communication
1
2003
8
0.010
Why?
Paracrine Communication
1
2003
12
0.010
Why?
Metaphase
1
2003
44
0.010
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2002
18
0.010
Why?
Cell Separation
1
2003
89
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
NAD+ Nucleosidase
1
2002
3
0.010
Why?
Biopsy
1
2005
592
0.010
Why?
Cell Communication
1
2003
69
0.010
Why?
Antigens, Differentiation
1
2002
17
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
135
0.010
Why?
Cohort Studies
1
2006
1414
0.010
Why?
Immunoglobulins
1
2002
80
0.010
Why?
Database Management Systems
1
2002
28
0.010
Why?
Reproducibility of Results
1
2005
1195
0.010
Why?
Logistic Models
1
2003
901
0.010
Why?
Magnetic Resonance Imaging
1
2003
1529
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description